BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 9697836)

  • 21. Initiation of NALT organogenesis is independent of the IL-7R, LTbetaR, and NIK signaling pathways but requires the Id2 gene and CD3(-)CD4(+)CD45(+) cells.
    Fukuyama S; Hiroi T; Yokota Y; Rennert PD; Yanagita M; Kinoshita N; Terawaki S; Shikina T; Yamamoto M; Kurono Y; Kiyono H
    Immunity; 2002 Jul; 17(1):31-40. PubMed ID: 12150889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The requirement of membrane lymphotoxin for the presence of dendritic cells in lymphoid tissues.
    Wu Q; Wang Y; Wang J; Hedgeman EO; Browning JL; Fu YX
    J Exp Med; 1999 Sep; 190(5):629-38. PubMed ID: 10477548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesenteric lymph nodes are critical for the induction of high-dose oral tolerance in the absence of Peyer's patches.
    Spahn TW; Weiner HL; Rennert PD; Lügering N; Fontana A; Domschke W; Kucharzik T
    Eur J Immunol; 2002 Apr; 32(4):1109-13. PubMed ID: 11920578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visualization of lymphotoxin-beta and lymphotoxin-beta receptor expression in mouse embryos.
    Browning JL; French LE
    J Immunol; 2002 May; 168(10):5079-87. PubMed ID: 11994460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of tumor necrosis factor and lymphotoxin on peripheral lymphoid tissue development.
    Ettinger R; Mebius R; Browning JL; Michie SA; van Tuijl S; Kraal G; van Ewijk W; McDevitt HO
    Int Immunol; 1998 Jun; 10(6):727-41. PubMed ID: 9678753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elimination of colonic patches with lymphotoxin beta receptor-Ig prevents Th2 cell-type colitis.
    Dohi T; Rennert PD; Fujihashi K; Kiyono H; Shirai Y; Kawamura YI; Browning JL; McGhee JR
    J Immunol; 2001 Sep; 167(5):2781-90. PubMed ID: 11509623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice.
    Koni PA; Sacca R; Lawton P; Browning JL; Ruddle NH; Flavell RA
    Immunity; 1997 Apr; 6(4):491-500. PubMed ID: 9133428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolated lymphoid follicle formation is inducible and dependent upon lymphotoxin-sufficient B lymphocytes, lymphotoxin beta receptor, and TNF receptor I function.
    Lorenz RG; Chaplin DD; McDonald KG; McDonough JS; Newberry RD
    J Immunol; 2003 Jun; 170(11):5475-82. PubMed ID: 12759424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the lymphotoxin beta receptor on follicular stromal cells in human lymphoid tissues.
    Murphy M; Walter BN; Pike-Nobile L; Fanger NA; Guyre PM; Browning JL; Ware CF; Epstein LB
    Cell Death Differ; 1998 Jun; 5(6):497-505. PubMed ID: 10200501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular basis for hematopoietic/mesenchymal interaction during initiation of Peyer's patch organogenesis.
    Honda K; Nakano H; Yoshida H; Nishikawa S; Rennert P; Ikuta K; Tamechika M; Yamaguchi K; Fukumoto T; Chiba T; Nishikawa SI
    J Exp Med; 2001 Mar; 193(5):621-30. PubMed ID: 11238592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin.
    De Togni P; Goellner J; Ruddle NH; Streeter PR; Fick A; Mariathasan S; Smith SC; Carlson R; Shornick LP; Strauss-Schoenberger J
    Science; 1994 Apr; 264(5159):703-7. PubMed ID: 8171322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postgestational lymphotoxin/lymphotoxin beta receptor interactions are essential for the presence of intestinal B lymphocytes.
    Newberry RD; McDonough JS; McDonald KG; Lorenz RG
    J Immunol; 2002 May; 168(10):4988-97. PubMed ID: 11994450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphotoxin-independent expression of TNF-related activation-induced cytokine by stromal cells in cryptopatches, isolated lymphoid follicles, and Peyer's patches.
    Taylor RT; Patel SR; Lin E; Butler BR; Lake JG; Newberry RD; Williams IR
    J Immunol; 2007 May; 178(9):5659-67. PubMed ID: 17442949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice.
    Alimzhanov MB; Kuprash DV; Kosco-Vilbois MH; Luz A; Turetskaya RL; Tarakhovsky A; Rajewsky K; Nedospasov SA; Pfeffer K
    Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9302-7. PubMed ID: 9256477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissecting the role of lymphotoxin in lymphoid organs by conditional targeting.
    Tumanov AV; Grivennikov SI; Shakhov AN; Rybtsov SA; Koroleva EP; Takeda J; Nedospasov SA; Kuprash DV
    Immunol Rev; 2003 Oct; 195():106-16. PubMed ID: 12969314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Membrane lymphotoxin contributes to anti-leishmanial immunity by controlling structural integrity of lymphoid organs.
    Wilhelm P; Riminton DS; Ritter U; Lemckert FA; Scheidig C; Hoek R; Sedgwick JD; Körner H
    Eur J Immunol; 2002 Jul; 32(7):1993-2003. PubMed ID: 12115620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis.
    Luther SA; Bidgol A; Hargreaves DC; Schmidt A; Xu Y; Paniyadi J; Matloubian M; Cyster JG
    J Immunol; 2002 Jul; 169(1):424-33. PubMed ID: 12077273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-beta receptor-IgG1 fusion protein.
    Ettinger R; Browning JL; Michie SA; van Ewijk W; McDevitt HO
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13102-7. PubMed ID: 8917551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The lymphotoxin pathway: beyond lymph node development.
    McCarthy DD; Summers-Deluca L; Vu F; Chiu S; Gao Y; Gommerman JL
    Immunol Res; 2006; 35(1-2):41-54. PubMed ID: 17003508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs.
    Rennert PD; Browning JL; Mebius R; Mackay F; Hochman PS
    J Exp Med; 1996 Nov; 184(5):1999-2006. PubMed ID: 8920886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.